ARTICLE | Clinical News
Recombinant osteogenic protein 1 regulatory update
January 8, 2001 8:00 AM UTC
Europe's Committee for Proprietary Medicinal Products (CPMP) issued a unanimous positive opinion to recommend marketing authorization for OP-1 in Europe. The product is a combination of OP-1 plus a c...